Article(id=1329835519170687048, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835512791150603, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.11.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1692633600000, receivedDateStr=2023-08-22, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987094919, onlineDateStr=2026-11-18, pubDate=1699545600000, pubDateStr=2023-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987094919, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987094919, creator=13701087609, updateTime=1794987094919, updator=13701087609, issue=Issue{id=1329835512791150603, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='11', pageStart='1133', pageEnd='1242', issueExtLink='null', onlineDate='null', pubDate='1699545600000', pubDateStr='2023-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794987093398, creator='13701087609', updateTime=1794988063154, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839580662051474, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835512791150603, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839580662051475, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835512791150603, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1139, endPage=1143, ext={EN=ArticleExt(id=1329835519380402249, articleId=1329835519170687048, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Review and prospect of targeted drugs for rheumatoid arthritis, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by multiple joint destruction, and in severe cases, there may be irreversible joint destruction and even systemic organ involvement. The therapeutic targets of RA have been constantly explored and updated. This article reviewed the new progress of biologics and targeted drugs for RA, to provide certain reference for clinical drug use.

, authors=Lu ZHAO1, Yuting CAO2, Wei LIU1, Huan LIU1, *, authorsList=Lu ZHAO, Yuting CAO, Wei LIU, Huan LIU, authorCompany=null, correspAuthors=Huan LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835519657226314, articleId=1329835519170687048, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=类风湿性关节炎靶向治疗药物的回顾及展望, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

类风湿性关节炎(rheumatoid arthritis,RA)是一种表现为多关节破坏的慢性自身免疫性疾病,严重者可有不可逆的关节破坏,甚至系统器官受累。对RA的治疗靶点一直处于不断探索及更新中,现综述RA治疗的生物制剂及靶向药物新进展,为临床用药提供一定参考。

, authors=赵璐1, 曹宇婷2, 刘薇1, 刘欢1, *, authorsList=赵璐, 曹宇婷, 刘薇, 刘欢, authorCompany=null, correspAuthors=刘欢, authorNote=

赵璐,住院医师,研究方向:关节内科疾病诊治。

, correspAuthorsNote=
刘欢,副主任医师,研究方向:关节内科疾病诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=4DaiUSwR2qf9RT/wHrpqhQ==, magXml=+uK8GWF6F92Ssa8Gn4aKLA==, pdfUrl=null, pdf=o6FHUVQlZVmHmTznTS5Jjg==, pdfFileSize=1525307, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=9hzTzyxL42Zo1giUXn9wVA==, mapNumber=null, fund=null)}, authors=[Author(id=1329835521569828946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835521636937812, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521569828946, language=EN, stringName=Lu ZHAO, firstName=Lu, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835521716629589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521569828946, language=CN, stringName=赵璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市光华中西医结合医院关节内科,上海 200052, bio={"content":"

赵璐,住院医师,研究方向:关节内科疾病诊治。

"}, bioImg=null, bioContent=

赵璐,住院医师,研究方向:关节内科疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)])]), Author(id=1329835521792127063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835521855041625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521792127063, language=EN, stringName=Yuting CAO, firstName=Yuting, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835521930539098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521792127063, language=CN, stringName=曹宇婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海中医药大学光华临床医学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521481748558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=2., ext=[AuthorCompanyExt(id=1329835521490137167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521481748558, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China), AuthorCompanyExt(id=1329835521502720080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521481748558, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海中医药大学光华临床医学院,上海 201203)])]), Author(id=1329835522022813788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835522140254302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522022813788, language=EN, stringName=Wei LIU, firstName=Wei, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835522211557471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522022813788, language=CN, stringName=刘薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市光华中西医结合医院关节内科,上海 200052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)])]), Author(id=1329835522278666337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835522349969507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522278666337, language=EN, stringName=Huan LIU, firstName=Huan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835522408689764, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522278666337, language=CN, stringName=刘欢, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海市光华中西医结合医院关节内科,上海 200052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)])])], keywords=[Keyword(id=1329835522526130277, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, language=EN, orderNo=1, keyword=rheumatoid arthritis), Keyword(id=1329835522589044838, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, language=EN, orderNo=2, keyword=targeted therapy), Keyword(id=1329835522656153703, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, language=EN, orderNo=3, keyword=autoimmune disease), Keyword(id=1329835522723262568, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, language=CN, orderNo=1, keyword=类风湿性关节炎), Keyword(id=1329835522786177129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, language=CN, orderNo=2, keyword=靶向治疗), Keyword(id=1329835522857480298, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, language=CN, orderNo=3, keyword=自身免疫性疾病)], refs=[Reference(id=1329835522949754987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update[J]. Ann Rheum Dis, 2020, 79(6): 685-699., articleTitle=null, refAbstract=null), Reference(id=1329835523021058156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Kubo S, Nakayamada S, Tanaka Y. JAK inhibitors for rheumatoid arthritis[J]. Expert Opin Investig Drugs, 2023, 32(4): 333-344., articleTitle=null, refAbstract=null), Reference(id=1329835523083972717, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Keystone EC, Breedveld FC, van der Heijde D, et al. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year effificacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension[J]. J Rheumatol, 2014, 41: 5-14., articleTitle=null, refAbstract=null), Reference(id=1329835523172053102, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Knight DM, Trinh H, Le J, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody[J]. Mol Immunol, 1993, 30(16): 1443-1453., articleTitle=null, refAbstract=null), Reference(id=1329835523251744879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Paleolog EM, Young S, Stark AC, et al. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis[J]. Arthritis Rheum, 1998, 41(7): 1258-1265., articleTitle=null, refAbstract=null), Reference(id=1329835523356602480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Maini RN, Elliott MJ, Brennan FM, et al. Monoclonal anti-TNF α antibody as a probe of pathogenesis and therapy of rheumatoid disease[J]. Immunol Rev, 1995, 144: 195-223., articleTitle=null, refAbstract=null), Reference(id=1329835523423711345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Yoo DH, Hrycaj P, Miranda P, et al. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study[J]. Ann Rheum Dis, 2013, 72(10): 1613-1620., articleTitle=null, refAbstract=null), Reference(id=1329835523490820210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Yoo DH, Racewicz A, Brzezicki J, et al. A phase Ⅲrandomized study to evaluate the efficacy and safety of CTP13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study[J]. Arthritis Res Ther, 2016, 18: 82., articleTitle=null, refAbstract=null), Reference(id=1329835523557929075, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Yoo DH, Prodanovic N, Jaworski J, et al. Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study[J]. Ann Rheum Dis, 2017, 76(2): 355-363., articleTitle=null, refAbstract=null), Reference(id=1329835523625037940, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Choe JY, Prodanovic N, Niebrzydowski J, et al. A randomised, double-blind, phase Ⅲ study comparing SB2, an infliximab biosimilar, to the infliximab reference product remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy[J]. Ann Rheum Dis, 2017, 76(1): 58-64., articleTitle=null, refAbstract=null), Reference(id=1329835523708924021, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Goffe B, Cather JC. Etanercept: an overview[J]. J Am Acad Dermatol, 2003, 49(Suppl 2): S105-S111., articleTitle=null, refAbstract=null), Reference(id=1329835523792810102, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Moots RJ, Xavier RM, Mok CC, et al. The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: results from a multinational, real-world clinical practice, non-interventional study[J]. PLoS One, 2017, 12(4): e0175207., articleTitle=null, refAbstract=null), Reference(id=1329835523872501879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial[J]. Lancet, 2004, 363(9410): 675-681., articleTitle=null, refAbstract=null), Reference(id=1329835523939610744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Yamanaka H, Kamatani N, Tanaka Y, et al. A comparative study to assess the efficacy, safety, and immunogenicity of YLB113 and the etanercept reference product for the treatment of patients with rheumatoid arthritis[J]. Rheumatol Ther, 2020, 7(1): 149-163., articleTitle=null, refAbstract=null), Reference(id=1329835524002525305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Chadwick L, Zhao S, Mysler E, et al. Review of biosimilar trials and data on etanercept in rheumatoid arthritis[J]. Curr Rheumatol Rep, 2018, 20(12): 84., articleTitle=null, refAbstract=null), Reference(id=1329835524061245562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Cvetkovic RS, Scott LJ. Adalimumab: a review of its use in adult patients with rheumatoid arthritis[J]. BioDrugs, 2006, 20(5): 293-311., articleTitle=null, refAbstract=null), Reference(id=1329835524128354427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment[J]. Arthritis Rheum, 2006, 54(1): 26-37., articleTitle=null, refAbstract=null), Reference(id=1329835525768327292, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Keystone EC, Kavanaugh AF, Sharp JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial[J]. Arthritis Rheum, 2004, 50(5): 1400-1411., articleTitle=null, refAbstract=null), Reference(id=1329835525856407677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu X, Hu R, Peng L, et al. Effificacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis[J]. Front Immunol, 2021, 12: 638444., articleTitle=null, refAbstract=null), Reference(id=1329835525927710846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Oldfield V, Plosker GL. Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis[J]. BioDrugs, 2009, 23(2): 125-135., articleTitle=null, refAbstract=null), Reference(id=1329835526007402623, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Inman RD, Baraliakos X, Hermann KA, et al. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study[J]. Arthritis Res Ther, 2016, 18(1): 304., articleTitle=null, refAbstract=null), Reference(id=1329835526070317184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Smolen JS, Kay J, Doyle M, et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study[J]. Arthritis Res Ther, 2015, 17(1): 14., articleTitle=null, refAbstract=null), Reference(id=1329835526129037441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Kerschbaumer A, Sepriano A, Smolen JS, et al. Effificacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis[J]. Ann Rheum Dis, 2020, 79(6): 744-759., articleTitle=null, refAbstract=null), Reference(id=1329835526204534914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Miyazaki Y, Nakano K, Nakayamada S, et al. Serum TNF-α levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study[J]. Arthritis Res Ther, 2021, 23(1): 154., articleTitle=null, refAbstract=null), Reference(id=1329835526330364035, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Takeuchi T, Kawanishi M, Nakanishi M, et al. Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 52-week result of a phase Ⅱ/Ⅲ study (OHZORA trial)[J]. Mod Rheumatol, 2023, 33(5): 883-890., articleTitle=null, refAbstract=null), Reference(id=1329835526414250116, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Ishiwatari-Ogata C, Kyuuma M, Ogata H, et al. Ozoralizumab, a humanized anti-TNFα NANOBODY® compound, exhibits efficacy not only at the onset of arthritis in a human TNF transgenic mouse but also during secondary failure of administration of an anti-TNFα IgG[J]. Front Immunol, 2022, 13: 853008., articleTitle=null, refAbstract=null), Reference(id=1329835526472970373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Raimondo MG, Biggioggero M, Crotti C, et al. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis[J]. Drug Des Dev Ther, 2017, 11: 1593-1603., articleTitle=null, refAbstract=null), Reference(id=1329835526531690630, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Burmester GR, Lin Y, Patel R, et al. Effificacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, doubleblind, parallel-group phase Ⅲ trial[J]. Ann Rheum Dis, 2017, 76(5): 840-847., articleTitle=null, refAbstract=null), Reference(id=1329835526594605191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Buch MH, Vital EM, Emery P. Abatacept in the treatment of rheumatoid arthritis[J]. Arthritis Res Ther, 2008, 10(Suppl 1): S5., articleTitle=null, refAbstract=null), Reference(id=1329835526674296968, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Harigai M, Ishiguro N, Inokuma S, et al. Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance[J]. Mod Rheumatol, 2019, 29(5): 747-755., articleTitle=null, refAbstract=null), Reference(id=1329835526741405833, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=De Vita S, Zaja F, Sacro S, et al. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells[J]. Arthritis Rheum, 2002, 46(8): 2029-2033., articleTitle=null, refAbstract=null), Reference(id=1329835526812709002, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Reddy V, Klein C, Klein C, et al. Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples[J]. Rheumatology (Oxford), 2017, 56(7): 1227-1237., articleTitle=null, refAbstract=null), Reference(id=1329835526879817867, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Kaegi C, Wuest B, Crowley C, et al. Systematic review of safety and efficacy of second- and third-generation CD20-targeting biologics in treating immune-mediated disorders[J]. Front Immunol, 2022, 12: 788830., articleTitle=null, refAbstract=null), Reference(id=1329835526959509644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka Y. The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?[J]. Rheumatology (Oxford), 2019, 58(Suppl 1): i1-i3., articleTitle=null, refAbstract=null), Reference(id=1329835527026618509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Nash P, Kerschbaumer A, Dörner T, et al. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement[J]. Ann Rheum Dis, 2021, 80(1): 71-87., articleTitle=null, refAbstract=null), Reference(id=1329835527097921678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Combe B, Kivitz A, Tanaka Y. et al. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase Ⅲ randomised clinical trial[J]. Ann Rheum Dis, 2021, 80(7): 848-858., articleTitle=null, refAbstract=null), Reference(id=1329835527181807759, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Rubbert-Roth A, Enejosa J, Pangan AL, et al. Trial of upadacitinib or abatacept in rheumatoid arthritis[J]. N Engl J Med, 2020, 383(16): 1511-1521., articleTitle=null, refAbstract=null), Reference(id=1329835527299248272, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Traves PG, Murray B, Campigotto F, et al. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib[J]. Ann Rheum Dis, 2021, 80(7): 865-875., articleTitle=null, refAbstract=null), Reference(id=1329835527370551441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Abuqayyas L, Chen PW, Dos Santos MT, et al. Pharmacokinetics and pharmacokinetic/pharmacodynamic properties of rozibafusp alfa, a bispecific inhibitor of BAFF and ICOSL: analyses of phase Ⅰ clinical trials[J]. Clin Pharmacol Ther, 2023, 114(2): 371-380., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)]), AuthorCompany(id=1329835521481748558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=2., ext=[AuthorCompanyExt(id=1329835521490137167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521481748558, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China), AuthorCompanyExt(id=1329835521502720080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521481748558, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海中医药大学光华临床医学院,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.11.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.11.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.11.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.11.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1699545600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
类风湿性关节炎靶向治疗药物的回顾及展望
赵璐 1 , 曹宇婷 2 , 刘薇 1 , 刘欢 1, *
世界临床药物 | 医药专论 2023,44(11): 1139-1143
收起
收藏切换
世界临床药物 |医药专论 2023 , 44 (11) : 1139 -1143
类风湿性关节炎靶向治疗药物的回顾及展望
全屏
[Author(id=1329835521569828946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835521636937812, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521569828946, language=EN, stringName=Lu ZHAO, firstName=Lu, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835521716629589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521569828946, language=CN, stringName=赵璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市光华中西医结合医院关节内科,上海 200052, bio={"content":"

赵璐,住院医师,研究方向:关节内科疾病诊治。

"}, bioImg=null, bioContent=

赵璐,住院医师,研究方向:关节内科疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)])]), Author(id=1329835521792127063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835521855041625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521792127063, language=EN, stringName=Yuting CAO, firstName=Yuting, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835521930539098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835521792127063, language=CN, stringName=曹宇婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海中医药大学光华临床医学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521481748558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=2., ext=[AuthorCompanyExt(id=1329835521490137167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521481748558, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China), AuthorCompanyExt(id=1329835521502720080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521481748558, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海中医药大学光华临床医学院,上海 201203)])]), Author(id=1329835522022813788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835522140254302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522022813788, language=EN, stringName=Wei LIU, firstName=Wei, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835522211557471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522022813788, language=CN, stringName=刘薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市光华中西医结合医院关节内科,上海 200052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)])]), Author(id=1329835522278666337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835522349969507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522278666337, language=EN, stringName=Huan LIU, firstName=Huan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835522408689764, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, authorId=1329835522278666337, language=CN, stringName=刘欢, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海市光华中西医结合医院关节内科,上海 200052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835521402056779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, xref=1., ext=[AuthorCompanyExt(id=1329835521410445388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China), AuthorCompanyExt(id=1329835521418833997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835519170687048, companyId=1329835521402056779, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市光华中西医结合医院关节内科,上海 200052)])])]
赵璐1, 曹宇婷2, 刘薇1, 刘欢1, *
作者信息
  • 1.上海市光华中西医结合医院关节内科,上海 200052
  • 2.上海中医药大学光华临床医学院,上海 201203
通讯作者:
刘欢,副主任医师,研究方向:关节内科疾病诊治。
作者简介:

赵璐,住院医师,研究方向:关节内科疾病诊治。

Review and prospect of targeted drugs for rheumatoid arthritis
Lu ZHAO1, Yuting CAO2, Wei LIU1, Huan LIU1, *
Affiliations
  • 1.Department of Arthropathy, Shanghai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200052, China
  • 2.GuangHua Clinical College of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
出版时间: 2023-11-10 doi: 10.13683/j.wph.2023.11.002
文章导航
收藏切换

类风湿性关节炎(rheumatoid arthritis,RA)是一种表现为多关节破坏的慢性自身免疫性疾病,严重者可有不可逆的关节破坏,甚至系统器官受累。对RA的治疗靶点一直处于不断探索及更新中,现综述RA治疗的生物制剂及靶向药物新进展,为临床用药提供一定参考。

类风湿性关节炎  /  靶向治疗  /  自身免疫性疾病

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by multiple joint destruction, and in severe cases, there may be irreversible joint destruction and even systemic organ involvement. The therapeutic targets of RA have been constantly explored and updated. This article reviewed the new progress of biologics and targeted drugs for RA, to provide certain reference for clinical drug use.

rheumatoid arthritis  /  targeted therapy  /  autoimmune disease
赵璐, 曹宇婷, 刘薇, 刘欢. 类风湿性关节炎靶向治疗药物的回顾及展望. 世界临床药物, 2023 , 44 (11) : 1139 -1143 . DOI: 10.13683/j.wph.2023.11.002
Lu ZHAO, Yuting CAO, Wei LIU, Huan LIU. Review and prospect of targeted drugs for rheumatoid arthritis[J]. World Clinical Drug, 2023 , 44 (11) : 1139 -1143 . DOI: 10.13683/j.wph.2023.11.002

参考文献 引证文献
排序方式:
[1]
Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update[J]. Ann Rheum Dis, 2020, 79(6): 685-699.
[2]
Kubo S, Nakayamada S, Tanaka Y. JAK inhibitors for rheumatoid arthritis[J]. Expert Opin Investig Drugs, 2023, 32(4): 333-344.
[3]
Keystone EC, Breedveld FC, van der Heijde D, et al. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year effificacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension[J]. J Rheumatol, 2014, 41: 5-14.
[4]
Knight DM, Trinh H, Le J, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody[J]. Mol Immunol, 1993, 30(16): 1443-1453.
[5]
Paleolog EM, Young S, Stark AC, et al. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis[J]. Arthritis Rheum, 1998, 41(7): 1258-1265.
[6]
Maini RN, Elliott MJ, Brennan FM, et al. Monoclonal anti-TNF α antibody as a probe of pathogenesis and therapy of rheumatoid disease[J]. Immunol Rev, 1995, 144: 195-223.
[7]
Yoo DH, Hrycaj P, Miranda P, et al. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study[J]. Ann Rheum Dis, 2013, 72(10): 1613-1620.
[8]
Yoo DH, Racewicz A, Brzezicki J, et al. A phase Ⅲrandomized study to evaluate the efficacy and safety of CTP13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study[J]. Arthritis Res Ther, 2016, 18: 82.
[9]
Yoo DH, Prodanovic N, Jaworski J, et al. Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study[J]. Ann Rheum Dis, 2017, 76(2): 355-363.
[10]
Choe JY, Prodanovic N, Niebrzydowski J, et al. A randomised, double-blind, phase Ⅲ study comparing SB2, an infliximab biosimilar, to the infliximab reference product remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy[J]. Ann Rheum Dis, 2017, 76(1): 58-64.
[11]
Goffe B, Cather JC. Etanercept: an overview[J]. J Am Acad Dermatol, 2003, 49(Suppl 2): S105-S111.
[12]
Moots RJ, Xavier RM, Mok CC, et al. The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: results from a multinational, real-world clinical practice, non-interventional study[J]. PLoS One, 2017, 12(4): e0175207.
[13]
Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial[J]. Lancet, 2004, 363(9410): 675-681.
[14]
Yamanaka H, Kamatani N, Tanaka Y, et al. A comparative study to assess the efficacy, safety, and immunogenicity of YLB113 and the etanercept reference product for the treatment of patients with rheumatoid arthritis[J]. Rheumatol Ther, 2020, 7(1): 149-163.
[15]
Chadwick L, Zhao S, Mysler E, et al. Review of biosimilar trials and data on etanercept in rheumatoid arthritis[J]. Curr Rheumatol Rep, 2018, 20(12): 84.
[16]
Cvetkovic RS, Scott LJ. Adalimumab: a review of its use in adult patients with rheumatoid arthritis[J]. BioDrugs, 2006, 20(5): 293-311.
[17]
Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment[J]. Arthritis Rheum, 2006, 54(1): 26-37.
[18]
Keystone EC, Kavanaugh AF, Sharp JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial[J]. Arthritis Rheum, 2004, 50(5): 1400-1411.
[19]
Lu X, Hu R, Peng L, et al. Effificacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis[J]. Front Immunol, 2021, 12: 638444.
[20]
Oldfield V, Plosker GL. Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis[J]. BioDrugs, 2009, 23(2): 125-135.
[21]
Inman RD, Baraliakos X, Hermann KA, et al. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study[J]. Arthritis Res Ther, 2016, 18(1): 304.
[22]
Smolen JS, Kay J, Doyle M, et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study[J]. Arthritis Res Ther, 2015, 17(1): 14.
[23]
Kerschbaumer A, Sepriano A, Smolen JS, et al. Effificacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis[J]. Ann Rheum Dis, 2020, 79(6): 744-759.
[24]
Miyazaki Y, Nakano K, Nakayamada S, et al. Serum TNF-α levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study[J]. Arthritis Res Ther, 2021, 23(1): 154.
[25]
Takeuchi T, Kawanishi M, Nakanishi M, et al. Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 52-week result of a phase Ⅱ/Ⅲ study (OHZORA trial)[J]. Mod Rheumatol, 2023, 33(5): 883-890.
[26]
Ishiwatari-Ogata C, Kyuuma M, Ogata H, et al. Ozoralizumab, a humanized anti-TNFα NANOBODY® compound, exhibits efficacy not only at the onset of arthritis in a human TNF transgenic mouse but also during secondary failure of administration of an anti-TNFα IgG[J]. Front Immunol, 2022, 13: 853008.
[27]
Raimondo MG, Biggioggero M, Crotti C, et al. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis[J]. Drug Des Dev Ther, 2017, 11: 1593-1603.
[28]
Burmester GR, Lin Y, Patel R, et al. Effificacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, doubleblind, parallel-group phase Ⅲ trial[J]. Ann Rheum Dis, 2017, 76(5): 840-847.
[29]
Buch MH, Vital EM, Emery P. Abatacept in the treatment of rheumatoid arthritis[J]. Arthritis Res Ther, 2008, 10(Suppl 1): S5.
[30]
Harigai M, Ishiguro N, Inokuma S, et al. Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance[J]. Mod Rheumatol, 2019, 29(5): 747-755.
[31]
De Vita S, Zaja F, Sacro S, et al. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells[J]. Arthritis Rheum, 2002, 46(8): 2029-2033.
[32]
Reddy V, Klein C, Klein C, et al. Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples[J]. Rheumatology (Oxford), 2017, 56(7): 1227-1237.
[33]
Kaegi C, Wuest B, Crowley C, et al. Systematic review of safety and efficacy of second- and third-generation CD20-targeting biologics in treating immune-mediated disorders[J]. Front Immunol, 2022, 12: 788830.
[34]
Tanaka Y. The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?[J]. Rheumatology (Oxford), 2019, 58(Suppl 1): i1-i3.
[35]
Nash P, Kerschbaumer A, Dörner T, et al. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement[J]. Ann Rheum Dis, 2021, 80(1): 71-87.
[36]
Combe B, Kivitz A, Tanaka Y. et al. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase Ⅲ randomised clinical trial[J]. Ann Rheum Dis, 2021, 80(7): 848-858.
[37]
Rubbert-Roth A, Enejosa J, Pangan AL, et al. Trial of upadacitinib or abatacept in rheumatoid arthritis[J]. N Engl J Med, 2020, 383(16): 1511-1521.
[38]
Traves PG, Murray B, Campigotto F, et al. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib[J]. Ann Rheum Dis, 2021, 80(7): 865-875.
[39]
Abuqayyas L, Chen PW, Dos Santos MT, et al. Pharmacokinetics and pharmacokinetic/pharmacodynamic properties of rozibafusp alfa, a bispecific inhibitor of BAFF and ICOSL: analyses of phase Ⅰ clinical trials[J]. Clin Pharmacol Ther, 2023, 114(2): 371-380.
2023年第44卷第11期
10
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.11.002
  • 接收时间:2023-08-22
  • 首发时间:2026-11-18
  • 出版时间:2023-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-08-22
基金
作者信息
    1.上海市光华中西医结合医院关节内科,上海 200052
    2.上海中医药大学光华临床医学院,上海 201203

通讯作者:

刘欢,副主任医师,研究方向:关节内科疾病诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.11.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏